30-year study of MSUD highlights critical need for more effective disease-modifying therapies

30-year study of MSUD highlights critical need for more effective disease-modifying therapies

30-year study of MSUD highlights critical need for more effective disease-modifying therapies

A new study analyzes 30 years of patient data and details the clinical course of 184 individuals with genetically diverse forms of Maple Syrup Urine Disease (MSUD), which is among the most volatile and dangerous inherited metabolic disorders.